Orsay, France

Arlette Tixidre


Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Gif sur Yvette, FR (1990)
  • Orsay, FR (1992 - 1999)

Company Filing History:


Years Active: 1990-1999

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Arlette Tixidre: Innovator in Pharmaceutical Chemistry

Introduction

Arlette Tixidre is a prominent inventor based in Orsay, France. She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. Her work focuses on innovative processes and compounds that have the potential to impact various therapeutic areas.

Latest Patents

Among her latest patents, Tixidre has developed a compound known as 1-2-(2,3-Dihydro-1H-inden-1-yl)ethyl!-4-(naphthalen-1-yl) piperazine. Additionally, she has created a process for the resolution of ethyl 4,4,4-trifluoro-3(R)-hydroxybutanoate. This process involves selectively hydrolyzing the ester functional group of the (S) enantiomer of ethyl (±)-4,4,4-trifluoro-3-hydroxybutanoate using a lipase in an aqueous medium. The non-hydrolyzed (R) enantiomer is then extracted for further use in the preparation of 4,4,4-trifluoro-1,3(R)-butanediol.

Career Highlights

Arlette Tixidre is currently employed at Synthelabo, where she continues to advance her research and development efforts. Her innovative approaches have garnered attention in the pharmaceutical industry, contributing to the development of new therapeutic agents.

Collaborations

Tixidre collaborates with notable colleagues, including Pascal George and Lydia Zard. Their combined expertise enhances the research environment and fosters innovation within their projects.

Conclusion

Arlette Tixidre is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new advancements in drug development. Her contributions, particularly in the area of enantiomer resolution, highlight her commitment to innovation and excellence in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…